These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22052111)

  • 21. Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.
    Shi Y; Zhai W; Wang B; Zhao D; Jin H; Wang Y; Zhang J; An H; Fu Z; Zhao K; Lu C
    Oncotarget; 2016 Dec; 7(49):80935-80942. PubMed ID: 27821814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association study of c.910A>G and c.1686C>G polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in the Chinese population.
    Xia WF; Ma XP; Li XR; Dong H; Yi JL
    Genet Mol Res; 2014 Feb; 13(1):1314-22. PubMed ID: 24634229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
    Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
    Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort.
    Chen JH; Wang YY; Lv WB; Gan Y; Chang W; Tian NN; Huang XH; Liu L; Yu XF; Chen SD
    World J Gastroenterol; 2016 Apr; 22(16):4183-90. PubMed ID: 27122668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma.
    Wang B; Yeh CB; Lein MY; Su CM; Yang SF; Liu YF; Tang CH
    Int J Med Sci; 2016; 13(4):304-9. PubMed ID: 27076788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
    Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
    J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population.
    Jung KW; Ha E; Yu GI; Kim SJ; Chung WJ; Jang BK; Lee JJ; Shin DH; Hwang JS
    Clin Chim Acta; 2009 Sep; 407(1-2):16-9. PubMed ID: 19545551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of miR-149C>T polymorphisms on the risk of hepatocellular carcinoma in a Chinese population.
    Liu MF; Chen WQ; He YZ; Gu YL
    Genet Mol Res; 2014 Sep; 13(3):7184-9. PubMed ID: 25222224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
    Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
    Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
    Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
    Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study.
    Tomoda T; Nouso K; Sakai A; Ouchida M; Kobayashi S; Miyahara K; Onishi H; Nakamura S; Yamamoto K; Shimizu K
    J Gastroenterol Hepatol; 2012 Apr; 27(4):797-804. PubMed ID: 22004425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Med Oncol; 2014 Dec; 31(12):301. PubMed ID: 25367853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N; Payungporn S; Chuaypen N; Pinjaroen N; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(12):5069-73. PubMed ID: 26163643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between P2RX7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Chinese Han Population.
    Duan S; Yu J; Han Z; Cheng Z; Liang P
    Med Sci Monit; 2016 Jun; 22():1916-23. PubMed ID: 27272229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.
    Zhao X; Wang T; Liu B; Wu Z; Yu S; Wang T
    Tumour Biol; 2015 Apr; 36(4):2551-8. PubMed ID: 25480412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study.
    Zhang J; Xue F; Chen S; Zhang D; Lu C; Tang G
    Medicine (Baltimore); 2017 Oct; 96(42):e7359. PubMed ID: 29049173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
    Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
    BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
    Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
    Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients.
    Qi JH; Wang J; Chen J; Shen F; Huang JT; Sen S; Zhou X; Liu SM
    BMC Cancer; 2014 Aug; 14():643. PubMed ID: 25176041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.